Stocks · Health care · Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc.

RVMD Clue Score22
United States Fiscal year ends December CIK 0001628171 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Mark A Goldsmith
6 Feb 2026
See Remarks
Exercised, kept
24,010
$0.54
$12.97K

What was left out

Form 4 filings counted 70
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 49
Sales straight out of an exercise 109
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,241,674
History held since 14 Feb 2020